<--- Back to Details
First PageDocument Content
Environment / Drug control law / Drug policy / Controlled substance / Environmental impact of pharmaceuticals and personal care products / Controlled Substances Act / Pharmacy / Medical prescription / Electronic Prescriptions for Controlled Substances / Drug Enforcement Administration / Pharmacology / Pharmaceutical sciences
Date: 2013-03-10 05:00:00
Environment
Drug control law
Drug policy
Controlled substance
Environmental impact of pharmaceuticals and personal care products
Controlled Substances Act
Pharmacy
Medical prescription
Electronic Prescriptions for Controlled Substances
Drug Enforcement Administration
Pharmacology
Pharmaceutical sciences

Microsoft Word - DEA Comment Letter - FINAL

Add to Reading List

Source URL: des.nh.gov

Download Document from Source Website

File Size: 366,40 KB

Share Document on Facebook

Similar Documents

SWGDRUG Meeting Minutes St. Louis, MO June 12-15, 2017 Core Committee Members (Present) Scott R. Oulton, Chair, Drug Enforcement Administration Christian Matchett, Vice-Chair, Southern Association of Forensic Scientists

DocID: 1v6FC - View Document

SWGDRUG Meeting Minutes Portland, ME July 10-12, 2012 Core Committee Members (present): Scott R. Oulton, Chair, Drug Enforcement Administration

DocID: 1ujyF - View Document

SWGDRUG Meeting Minutes San Diego, CA August 12-14, 2014 Core Committee Members (Present) Scott R. Oulton, Chair, Drug Enforcement Administration

DocID: 1tPaz - View Document

    Special​ ​Agent​ ​Finn​ ​Selander​ ​(Ret.)  U.S.​ ​Drug​ ​Enforcement​ ​Administration  Phoenix,​ ​AZ 

DocID: 1tLOb - View Document

13th National Take Back Day April 29, 2017 DRUG ENFORCEMENT ADMINISTRATION DIVERSION CONTROL PROGRAM

DocID: 1txvX - View Document